Makers of WHO approved vaccines should prioritise COVAX, not shareholder profit: Tedros

Updated: Nov 4 2021 10:54PM

Geneva, Nov 4 (PTI) The chief of the World Health Organisation on Thursday called on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritise COVAX, not shareholder profit.

WHO Director General Tedros Adhanom Ghebreyesus made the remarks a day after the WHO granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin.

"Yesterday we added another new tool, with the Emergency Use Listing of Covaxin, the 8th vaccine to receive WHO validation for safety, efficacy and quality," he said at a media briefing on COVID-19.